Mark J Bishton (Mark Bishton)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Topics

Epstein Barr Virus

Hodgkin Lymphoma

Diffuse Large B Cell Lymphoma

Lipopolysaccharide Induced

Top Venues

British journal of haematology

American journal of hematology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal of internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Mark J Bishton, Colin J Crooks, Timothy R Card, Prof Joe West
Ethnicity and socio-economic status affects the incidence and survival of hepatosplenic T-cell lymphoma. British journal of haematology (2024)
Mark J Bishton, Colin J Crooks, Timothy R Card, Prof Joe West
Ethnicity and socio-economic status affects the incidence and survival of hepatosplenic T-cell lymphoma. British journal of haematology 204 (6) (2024)
Suzanne O Arulogun, Duncan Brian, Harshita Goradia, Aaron Cooney, Tobias Menne, RayMun Koo, Aideen T O'Neill, Josephine M I Vos, Guy Pratt, Deborah Turner, Kirsty Marshall, Kate Manos, Claire Anderson, Maria Gavriatopoulou, Charalampia Kyriakou, Marie J Kersten, Monique C Minnema, Eirini Koutoumanou, Dima El-Sharkawi, Kim Linton, Dipti Talaulikar, Helen McCarthy, Mark J Bishton, George Follows, Ashutosh Wechalekar, Shirley P D'Sa
Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinaemia: patient outcomes and impact of bendamustine dosing. American journal of hematology (2023)
Adrian G Minson, Nada Hamad, Pietro R Di Ciaccio, Dipti Talaulikar, Matthew Ku, Sumita Ratnasingam, Chan Yoon Y Cheah, Costas K Yannakou, Mark J Bishton, Zi Yun Ng, Shivam Agrawal, Andrew McQuillan, Anna Johnston, Emily Choong, Kimberly Wong, James McQuillan, Ashley Beekman, Eliza A Hawkes, Michael Dickinson
Death from mantle cell lymphoma limits sequential therapy, particularly after first relapse: Patterns of care and outcomes in a series from Australia and the United Kingdom. British journal of haematology (2023)
Suzanne O Arulogun, Duncan Brian, Harshita Goradia, Aaron Cooney, Tobias Menne, RayMun Koo, Aideen T O'Neill, Josephine M I Vos, Guy Pratt, Deborah Turner, Kirsty Marshall, Kate Manos, Claire Anderson, Maria Gavriatopoulou, Charalampia Kyriakou, Marie J Kersten, Monique C Minnema, Eirini Koutoumanou, Dima El-Sharkawi, Kim Linton, Dipti Talaulikar, Helen McCarthy, Mark J Bishton, George Follows, Ashutosh Wechalekar, Shirley P D'Sa
Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing. American journal of hematology (2023)
Katharine Louise Lewis, Lasse Hjort Kyneb Jakobsen, Diego R Villa, Karin E Smedby, Kerry Joane Savage, Toby Andrew Eyre, Kate Cwynarski, Mark J Bishton, Christopher Paul Fox, Eliza A Hawkes, Matthew John Maurer, Tarec C El-Galaly, Chan Yoon Y Cheah, null null
High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Hanhua Liu, Charles A Stiller, Colin J Crooks, Brian Rous, Mary Bythell, John Broggio, Judith Rankin, Vasanta Nanduri, Peter Lanyon, Tim R Card, Lu Ban, Lucy Elliss-Brookes, Jennifer M Broughan, Lizz Paley, Kwok Wong, Andrew Bacon, Mark J Bishton, Prof Joe West
Incidence, prevalence and survival in patients with Langerhans cell histiocytosis: A national registry study from England, 2013-2019. British journal of haematology 199 (5) (2022)
Sarah J Halligan, Matthew J Grainge, Nicolas Martinez-Calle, Christopher P Fox, Mark J Bishton
Population-based cohort study of the efficacy of brentuximab vedotin in relapsed systemic anaplastic large-cell lymphoma using Public Health England data. British journal of haematology (2021)
Mark J Bishton, Peter Stilwell, Tim R Card, Peter Lanyon, Lu Ban, Lucy Ellis-Brookes, Jessica Manson, Vasanta Nanduri, Kate Earp, Luke Flower, Raj Amarnani, Judith Rankin, Ethan S Sen, Rachel S Tattersall, Colin J Crooks, Jeanette Aston, Veronika Siskova, Prof Joe West, Mary Bythell
A validation study of the identification of haemophagocytic lymphohistiocytosis in England using population-based health data. British journal of haematology 194 (6) (2021)
Prof Joe West, Tim R Card, Mark J Bishton, Peter Lanyon, Lu Ban, Mary Bythell, Lucy Elliss-Brookes, Jessica J Manson, Vasanta Nanduri, Judith Rankin, Rachel S Tattersall, Colin J Crooks
Incidence and survival of haemophagocytic lymphohistiocytosis: A population-based cohort study from England. Journal of internal medicine (2021)
Alexandros Rampotas, Matthew R Wilson, Oliver C Lomas, Nicholas Denny, Heather Leary, Graeme Ferguson, Pamela McKay, Tim Ebsworth, Jonathan Miller, Nimish Shah, Nicolas Martinez-Calle, Mark J Bishton, Angharad Everden, David Tucker, Ezzat Elhassadi, Brian Hennessy, Dearbhla Doherty, Steve Prideaux, Rehman Faryal, Amjad Hayat, Clodagh Keohane, Helen Marr, Adam Gibb, Rachael Pocock, Jonathan Lambert, Rachel Lacey, Nagah Elmusharaf, Ruth Clifford, Toby Andrew Eyre
Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysis. British journal of haematology 194 (2) (2021)
Allison Barraclough, Mark J Bishton, Chan Yoon Y Cheah, Diego R Villa, Eliza A Hawkes
The diagnostic and therapeutic challenges of Grade 3B follicular lymphoma. British journal of haematology 195 (1) (2021)
Furqaan Ahmed Kaji, Nicolas Martinez-Calle, Mark J Bishton, Rocio Figueroa-Mora, Joanne Adlington, Michael O'Donoghue, Stuart Smith, Paul Byrne, Simon Paine, Vishakha Sovani, Dorothee Auer, Eleanor James, Eric M Bessell, Matthew J Grainge, Christopher P Fox
Improved survival outcomes despite older age at diagnosis: an era-by-era analysis of patients with primary central nervous system lymphoma treated at a single referral centre in the United Kingdom. British journal of haematology 195 (4) (2021)
Mark J Bishton, Simon Rule, William Wilson, Deborah Turner, Russell Patmore, Laura Clifton-Hadley, Andrew McMillan, Richard Lush, Andrew Haynes
The UK NCRI study of chlorambucil, mitoxantrone and dexamethasone (CMD) versus fludarabine, mitoxantrone and dexamethasone (FMD) for untreated advanced stage follicular lymphoma: molecular response strongly predicts prolonged overall survival. British journal of haematology 190 (4) (2020)
Allison Barraclough, Musa Alzahrani, Marianne Schmidt Ettrup, Mark J Bishton, Chris van Vliet, Pedro Farinha, Clare Gould, Simone Birch, Laurie H Sehn, Vishakha Sovani, Mitchell Steven Ward, Bradley Augustson, Jorne Biccler, Joseph M Connors, David W Scott, Maher K Gandhi, Kerry J Savage, Tarec Christoffer El-Galaly, Diego R Villa, Chan Yoon Y Cheah
COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study. Blood advances 3 (13) (2020)
Toby Andrew Eyre, Nicolas Martinez-Calle, Catherine Hildyard, David W Eyre, Hannah Plaschkes, John Griffith, Julia Wolf, Paul A Fields, Arief Gunawan, Rebecca Oliver, Stephen Booth, Andrew McMillan, Christopher P Fox, Mark J Bishton, Graham P Collins, Chris S R Hatton
Male gender is an independent predictor for worse survival and relapse in a large, consecutive cohort of elderly DLBCL patients treated with R-CHOP. British journal of haematology 186 (4) (2019)
Toby Andrew Eyre, Amy A Kirkwood, Julia Wolf, Catherine Hildyard, Carolyn Mercer, Hannah Plaschkes, John Griffith, Paul Fields, Arief Gunawan, Rebecca Oliver, Stephen Booth, Nicolas Martinez-Calle, Andrew McMillan, Mark J Bishton, Christopher P Fox, Graham P Collins, Chris S R Hatton
Stand-alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R-CHOP and is associated increased infection-related toxicity. British journal of haematology 187 (2) (2019)
Matthew R Wilson, Timothy Bagguley, Alexandra G Smith, Eve Roman, Russell Patmore, Katharine Hanlon, Mike Leach, Mark J Bishton, Cathy Burton, Pamela McKay
Frontline management of nodular lymphocyte predominant Hodgkin lymphoma - a retrospective UK multicentre study. British journal of haematology 186 (6) (2019)
Nicolás Martinez-Calle, Sarah Hartley, Matthew Ahearne, Benjamin Kasenda, Amy Beech, Helen Knight, Constantine Balotis, Ben Kennedy, Simon Wagner, Martin J S Dyer, Dean Smith, Andrew K McMillan, Fiona Miall, Mark J Bishton, Christopher Paul Fox
Kinetics of T-cell subset reconstitution following treatment with bendamustine and rituximab for low-grade lymphoproliferative disease: a population-based analysis. British journal of haematology 184 (6) (2018)